Response to diazepam in children with malaria-induced seizures

dc.contributor.author	Ikumi, ML
dc.contributor.author	Muchohi, SN
dc.contributor.author	Kokwaro, GO
dc.contributor.author	Kokwaro, G
dc.contributor.author	Newton, CR
dc.date.accessioned	2013-06-10T11:27:20Z
dc.date.available	2013-06-10T11:27:20Z
dc.date.issued	2008
dc.identifier.citation	Epilepsy Res. 2008 Dec;82(2-3):215-8. doi: 10.1016/j.eplepsyres.2008.08.002. Epub 2008 Sep 19	en
dc.identifier.uri	http://www.ncbi.nlm.nih.gov/pubmed/18804958
dc.identifier.uri	http://erepository.uonbi.ac.ke:8080/xmlui/handle/123456789/30695
dc.description.abstract	Malaria infection reduces the binding capacity of benzodiazepine receptors in mice. We studied the efficacy of diazepam terminating seizures in children with falciparum malaria. Diazepam stopped seizures in fewer patients with malaria parasitaemia (chi(2)=3.93, P=0.047) and those with clinical diagnosis of malaria (chi(2)=9.84, P=0.002) compared to those without. However malaria was not identified as an independent risk factor for diazepam's failure to stop seizures in children.	en
dc.language.iso	en	en
dc.publisher	University of Nairobi	en
dc.title	Response to diazepam in children with malaria-induced seizures	en
dc.type	Article	en
local.publisher	College of Humanities Sciences	en